Sinohealth Technology Holdings Limited filed its Monthly Return for the period ended 31 May 2026, confirming that both authorised and issued share capital remained unchanged during the month.
Authorised Share Capital • Class: Ordinary shares • Authorised amount: 2.00 billion shares at a par value of US$0.01, equivalent to US$20.00 million. No increase or decrease was recorded.
Issued Share Capital and Public Float • Issued shares (excluding treasury shares): 451.77 million, unchanged versus end-April 2026. • Treasury shares: Nil. • Public float: 16.45% of issued shares, equating to roughly 74.29 million shares, meeting Main Board Rule 13.32D(1)/19A.28D(1) requirements.
Equity-Linked Instruments • Share options outstanding: none. • Unutilised option mandate: up to 45.00 million shares remain available under the approved Share Option Scheme (approved 27 April 2022). • No warrants, convertible securities, or other share-issuance arrangements were reported for the month.
Capital Movements • Total increase in issued shares: 0 shares. • Total change in treasury shares: 0 shares.
Governance The submission was signed by Executive Director Ms Wu Yushu on 4 June 2026, affirming the accuracy of the disclosures.
With no equity issuance, repurchase, or conversion activities in May, Sinohealth Technology maintains a steady capital structure while remaining in full compliance with Hong Kong Stock Exchange public float rules.
Comments